Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)
Phase 3
Not yet recruiting
- Conditions
- Acute Decompensated Heart Failure
- Interventions
- Device: Reprieve System
- First Posted Date
- 2025-03-27
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Reprieve Cardiovascular, Inc
- Target Recruit Count
- 400
- Registration Number
- NCT06898515
- Locations
- 🇺🇸
University of California Irvine, Irvine, California, United States
🇺🇸Trinity Health Ann Arbor Hospital, Ann Arbor, Michigan, United States
🇺🇸St. Louis VA, St. Louis, Missouri, United States
EU Sites: Fluid Management of Acute Decompensated Heart Failure With Reprieve Decongestion Management System (FASTR-EU)
Not Applicable
Completed
- Conditions
- Acute Decompensated Heart Failure
- Interventions
- Drug: Diuretic (furosemide, bumetanide, torsemide, hydrochlorothiazide, and/or acetazolamide)Device: Reprieve Decongestion Management System
- First Posted Date
- 2024-04-12
- Last Posted Date
- 2025-03-10
- Lead Sponsor
- Reprieve Cardiovascular, Inc
- Target Recruit Count
- 12
- Registration Number
- NCT06362668
- Locations
- 🇳🇱
University Medical Center Groningen, Groningen, Netherlands
🇵🇱Wroclaw Medical University, Wrocław, Poland
Reprieve System Pilot Study
Not Applicable
Recruiting
- Conditions
- Acute Decompensated Heart Failure
- Interventions
- Device: Reprieve System
- First Posted Date
- 2024-02-22
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- Reprieve Cardiovascular, Inc
- Target Recruit Count
- 50
- Registration Number
- NCT06272734
- Locations
- 🇬🇪
Tbilisi Heart and Vascular Clinic, Tbilisi, Georgia
Fluid Management of Acute Decompensated Heart Failure Subjects Treated with Reprieve Decongestion Management System (DMS)
Not Applicable
Completed
- Conditions
- Acute Decompensated Heart Failure
- Interventions
- Device: Reprieve Decongestion Management SystemDrug: Diuretic
- First Posted Date
- 2021-12-30
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- Reprieve Cardiovascular, Inc
- Target Recruit Count
- 100
- Registration Number
- NCT05174312
- Locations
- 🇺🇸
MedStar Washington Hospital Center, Washington, District of Columbia, United States
🇺🇸Duke University Hospital, Durham, North Carolina, United States
🇺🇸Cone Health, Greensboro, North Carolina, United States
Reprieve Cardiovascular System for the Treatment of Subjects With Acute Decompensated Heart Failure Mechanistic Study
Not Applicable
Completed
- Conditions
- Heart Failure
- Interventions
- Device: Reprieve Cardiovascular SystemOther: Fluid Management
- First Posted Date
- 2021-08-20
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- Reprieve Cardiovascular, Inc
- Target Recruit Count
- 31
- Registration Number
- NCT05015764
- Locations
- 🇬🇪
Israeli-Georgian Medical Research Clinic Helsicore, Tbilisi, Georgia
© Copyright 2025. All Rights Reserved by MedPath